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Abstract
Background: Dengue hemorrhagic fever (DHF) is a severe life-threatening form of dengue infection. Low platelet
count is one of the characteristic clinical manifestations in patients with severe dengue. However, little is known
about genetic factors in the host that cause low platelet count in patients with dengue.
Methods: A previous genome-wide association study of hematological and biochemical traits identified single
nucleotide polymorphisms (SNPs) associated with low platelet count in healthy subjects. To examine the possible
association of these SNPs with DHF, 918 Thai patients with dengue [509 patients with DHF and 409 with dengue
fever (DF)] were genotyped for five SNPs: rs5745568 in BAK1, rs6141 in THPO, rs6065 in GP1BA, rs739496 in SH2B3,
and rs385893 in RCL1. In addition, rs4804803 in CD209, that has been reported to be associated with dengue
infection, was also genotyped to examine if rs4804803 affects the association detected in this study.
Results: The allele frequencies of each SNP were compared between the DHF and DF groups. Among the five
SNPs, the G allele of rs5745568 in BAK1 was significantly associated with a risk for DHF [P = 0.006 and crude odd
ratio (95 % confidence interval) = 1.32 (1.09–1.60)]. The association of this allele with DHF was also significant in a
logistic regression analysis adjusted for age, sex, hospital (i.e., geographic region), immune status (i.e., primary or
secondary infection), and virus serotype [P = 0.016 and adjusted odd ratio (95 % confidence interval) = 1.29 (1.05–1.
58)]. The result was not influenced by rs4804803 [P = 0.0167 and adjusted OR (95 % CI) = 1.29 (1.05–1.58)]. No other
SNPs including rs4804803 showed significant association.
Conclusions: The low-level constitutive production of platelets caused by the G allele of rs5745568 seems to
increase the risk of bleeding in dengue infection. Our results suggest that BCL-2 homologous antagonist/killer (BAK)
protein, encoded by BAK1, plays a crucial role in the pathogenesis of DHF.
Background
Dengue is a mosquito-borne acute systemic viral infec-
tion caused by the dengue virus (DEN) [1]. DEN is a
small single-stranded RNA virus consisting of four dis-
tinct serotypes, DEN-1 to DEN-4 [2]. The severity of
DEN infection ranges from a mild disease, dengue fever
(DF), to the severe dengue hemorrhagic fever (DHF),
which can culminate in dengue shock syndrome (DSS)
and death [3]. The vast majority of severe dengue cases
occur in children and are currently a leading cause of
hospital admission and death among children in Asia
[4]. The transmission has been estimated to occur in up
to 124 countries [5], with at least 50 million infected
cases per year [6], including 250,000 cases of DHF/DSS
[7]. A recent publication claims that this number may be
as high as 390 million [8].
There are a number of factors associated with DHF [9],
including host-related factors. Low platelet count is
known to be a characteristic clinical manifestation in se-
vere dengue, and a platelet count of less than 50,000/mm3
on days 5 to 7 after the onset of illness is associated with
the development of complications, such as bleeding and
shock [10, 11].
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A recent genome-wide association study (GWAS) of
hematological and biochemical traits identified six SNPs
associated with low platelet count in healthy subjects [12].
These SNPs might also affect susceptibility to severe den-
gue. In the present study, to elucidate genetic factors in
the host that influence the pathogenesis of dengue infec-
tion, the association of SNPs involved in low platelet
count was examined in patients with dengue.
Methods
Patients
A total of 918 Thai patients with dengue who were
treated at Ratchaburi Hospital and Lampang Hospital,
Thailand, between 1999 and 2004 were investigated. All
patients were ≤15 years old at diagnosis. They were con-
firmed as having DEN infection by dengue IgM/IgG
capture enzyme-linked immunosorbent assay (ELISA),
reverse transcriptase polymerase chain reaction (RT-
PCR), and/or DEN isolation at the Arbovirus Laboratory,
National Institute of Health, Department of Medical Sci-
ences, Ministry of Public Health, Thailand. The patients
were classified into two groups, DHF and DF, according
to the WHO 1997 criteria [3]. In this study, DSS (i.e.,
DHF grades III and IV) is regarded as DHF. In brief, DF
was defined as an acute illness with various nonspecific
symptoms (e.g., headache, myalgia, arthralgia, rashes,
and leucopenia). Patients with DHF had hemorrhagic
manifestations, plasma leakage, and thrombocytopenia.
Thrombocytopenia was diagnosed by platelet count of
less than 100 000 per mm3 and a greater than 20 % in-
crease in the packed cell volume from the baseline.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the QIAamp Blood Kit (Qiagen, Hilden,
Germany). Patients with dengue were genotyped for five
SNPs, rs5745568 in BAK1, rs6141 in THPO, rs6065 in
GP1BA, rs739496 in SH2B3, and rs385893 in RCL1,
using TaqMan SNP genotyping assays (Applied Biosys-
tems, Foster City, CA, USA). These SNPs were reported
to be associated with low platelet count in a recent
GWAS [12]. Although rs7775698 (HBS1L) also showed
a significant association with low platelet count [12], it
was not analyzed in the present study because the Taq-
Man probe was not available. In addition, rs4804803 in
CD209 was also genotyped to examine the possible
interaction with rs5745568 in BAK1.
Statistical analysis
The deviation from Hardy–Weinberg equilibrium was
examined in both DHF and DF groups using a web tool
[13]. To assess the association of each SNP with severe
dengue, allele frequencies were compared using a Chi-
square test between the two groups. The allelic odds
ratio (OR) and the 95 % confidence interval (95 % CI)
were calculated for the allele that was previously shown
to be associated with low platelet count [12], which
allowed us to examine the consistency in the direction
of association, because low platelet count is likely to in-
crease the risk for DHF in patients with dengue. Domin-
ant and recessive models were examined for rs5745568
in BAK1. To control possible confounding factors, such
as age, sex, hospital (i.e., geographic region), immune
status (i.e., primary or secondary infection), and virus
serotype, a logistic regression analysis adjusted for these
independent variables was performed. In this analysis,
the number of risk alleles (i.e., 0, 1, and 2) was used as
an independent variable. The significance level was set
at P < 0.05. SNPinfo [14] was used for in silico predictions
of functional significance and for detection of SNPs in
linkage disequilibrium (LD) with rs5745568 (r2 ≥ 0.8) in
the HapMap-CHB and HapMap-JPT populations [15, 16].
Results and discussion
A total of 918 confirmed patients with dengue, including
509 patients with DHF and 409 patients with DF, were
investigated in this study (Table 1). They were genotyped
for six SNPs. Of which, five SNP, rs5745568 in BAK1,
rs6141 in THPO, rs6065 in GP1BA, rs739496 in SH2B3,
and rs385893 in RCL1, were previously reported to be
associated with low platelet count [12]. Although
rs7775698 (HBS1L) also showed a significant association
with low platelet count in a previous GWAS [12], it was
not analyzed in the present study because rs7775698
could not be successfully genotyped. The genotype and
allele frequencies of the SNPs in each dengue group are
Table 1 Patient characteristics (total n = 918)
Characteristic DHF n = 509 DF n = 409
Sex
Male 276 213
Female 233 196
Hospital
Lampang 134 172
Ratchaburi 375 237
Immune status
Primary 65 94
Secondary 444 314
Serotype of virus
D1 151 153
D2 197 109
D3 79 92
D4 81 54
Agea (years) 10 (0–15) 9.0 (1–15)
a Median (minimum–maximum)
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shown in Table 2. No SNP showed a significant devi-
ation from the Hardy-Weinberg equilibrium in either
dengue group. Among SNPs examined in this study,
rs5745568 in BKA1 was the only SNP that was signifi-
cantly associated with a risk for DHF [P = 0.006 and
crude OR (95 % CI) = 1.32 (1.09–1.60)]. A further ana-
lysis based on the genotype revealed that the GG geno-
type of rs5745568 significantly increased a risk for DHF
compared to GT and TT [P = 0.003 and crude OR (95 %
CI) = 1.50 (1.15–1.95)], while GG and GT did not signifi-
cantly increase a risk compared to TT [P = 0.279 and
crude OR (95 % CI) = 1.26 (0.83–1.93)], indicating that a
recessive model best explains the association of G allele
of rs5745568 with DHF. The association of rs5745568-G
with DHF was also significant in a logistic regression ana-
lysis adjusted for age, sex, hospital, immune status, and
virus serotype [P = 0.016 and adjusted OR (95 % CI) = 1.29
(1.05–1.58)]. The other SNPs showed no significant asso-
ciation in the logistic regression analyses (Table 2).
Several studies have shown significant association of a
CD209 promoter SNP (rs4804803) with DF or DHF
[17–19]. To examine if a CD209 promoter SNP affects
the association of BAK1 SNP with DHF, we analyzed
dengue patients for rs4804803. The rs4804803 SNP was
not significantly associated with DHF in this study
(Table 2). A logistic regression analysis adjusted for age,
sex, hospital, immune status, virus serotype, and geno-
type of rs4804803 revealed that rs5745568 was signifi-
cantly associated with DHF [P = 0.0167 and adjusted OR
(95 % CI) = 1.29 (1.05–1.58)]. Thus, we conclude that
the association of rs5745568 with DHF is independent
of rs4804803.
Although the direct association of rs5745568-G with
low platelet count in patients with dengue was not exam-
ined in this study, rs5745568-G has been reported to be
associated with low platelet count in healthy subjects [12].
Together with our results, the low-level constitutive pro-
duction of platelets caused by the G allele of rs5745568
Table 2 Association of SNPs with DHF
SNP ID (gene) Genotype
(Allele)
Patients with dengue Chi-square test Logistic regression analysis
DHF DF Crude OR (95 % CI) P-value Adjusted OR (95 % CI) P-value
rs5745568 (BAK1) TT 48 47
GT 191 187
GG 265 173
G-allele 721 (71.5 %) 533 (65.5 %) 1.32 (1.09–1.60) 0.006 1.29 (1.05–1.58) 0.016
rs6141 (THPO) TT 82 70
CT 260 189
CC 164 148
C-allele 588 (58.1 %) 485 (59.6 %) 0.94 (0.78–1.14) 0.520 0.98 (0.80–1.19) 0.844
rs6065 (GP1BA) TT 2 0
CT 37 42
CC 467 366
C-allele 971 (96.0 %) 774 (94.9 %) 1.29 (0.83–2.00) 0.263 1.35 (0.85–2.14) 0.203
rs739496 (SH2B3) AA 18 12
AG 137 114
GG 350 281
A-allele 173 (17.1 %) 138 (17.0 %) 1.01 (0.79–1.29) 0.921 0.96 (0.74–1.24) 0.731
rs385893 (RCL1) TT 49 39
CT 200 165
CC 258 205
T-allele 298 (29.4 %) 243 (29.7 %) 0.98 (0.80–1.21) 0.882 1.02 (0.83–1.25) 0.886
rs4804803 (CD209) AA 411 323
GA 92 77
GG 4 8
G-allele 100 (9.8 %) 93 (11.4 %) 0.85 (0.63–1.15) 0.288 0.83 (0.61–1.13) 0.242
Frequencies are shown in parentheses (%). The odds ratio (OR) of rs5745568 in BAK1, rs6141 in THPO, rs6065 in GP1BA, rs739496 in SH2B3, and rs385893 in RCL1
was calculated for the allele associated with low platelet count in a previous GWAS [12]. The OR of rs4804803 in CD209 was calculated for the G allele. Genotype
frequencies at SNPs examined did not deviate from those expected from the Hardy–Weinberg equilibrium in DHF and DF groups
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may increase the risk of bleeding in dengue infection.
To fully understand the biological significance of
rs5745568 in the pathogenesis of dengue infection, the
difference in the time course of the platelet count
among dengue patients with different genotypes re-
quires to be studied in future.
The rs5745568 SNP is located upstream of BAK1. To
estimate the functional significance of rs5745568, an in
silico analysis [14] was performed. The rs5745568 was
predicted to be located in the putative binding sites of
various transcription factors. Although the expression
level of BAK1 remains to be studied in patients with
dengue, the BAK1 expression level may vary among ge-
notypes of rs5745568. At this locus, a total of eight SNPs
were in LD (r2 ≥ 0.8) with rs5745568 in the HapMap-
CHB or HapMap-JPT population (data not shown),
which raises the possibility that the significant associ-
ation of the G allele of rs5745568 with a risk for DHF
may be explained by another causative variant in LD
with rs5745568. Thus, it should be noted that rs5745568
may not be primarily associated with DHF.
BCL-2 homologous antagonist/killer (BAK), encoded
by BAK1, is a member of the BCL-2 family of apoptosis
regulators, including pro-apoptotic (BAX, BAD, BAK,
and BOK) and anti-apoptotic (BCL-2, BCL-XL, and
BCL-W) proteins. Bak is responsible for mediating plate-
let death in mice [20], which implies that the G allele of
rs5745568 may be associated with a higher expression
level of BAK in patients with dengue as well as in
healthy individuals. The present results suggest that
BAK plays a crucial role in the pathogenesis of DHF and
is a potential target of therapy for DHF.
Conclusions
The G allele of rs5745568 in BAK1 was significantly as-
sociated with a risk for DHF. Although the association
of the G allele of rs5745568 with low platelet count in
patients with dengue remains to be confirmed in future
studies, the present results suggest that the BAK protein,
encoded by BAK1, plays a crucial role in the pathogen-
esis of DHF.
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